Article
Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
Drug metabolism and drug interactions - 1 Jan 2014
Cerda Alvaro, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Crespo
Abstract excerpt
Phase I and II drug metabolizing enzymes (DMEs) play an important role in biotransformation of endogenous and exogenous compounds including drugs currently used in pharmacoterapy. Moreover, the genetic variability of DMEs causes important interindividual differences in drug and metabolite exposure, drug response, and risk of adverse drug reactions. We reviewed pharmacogenetics/pharmacogenomics (PGx) studies that...
Topics
- Arylamine N-Acetyltransferase
- Biotransformation
- Brazil
- Cytochromes
- Genetic Variation
- Glucuronosyltransferase
- Glutathione Transferase
- Humans
- Methyltransferases
- Pharmacogenetics
- Polymorphism, Genetic
